Volume control and left ventricular hypertrophy in patients with end-stage renal disease

被引:0
|
作者
De Francisco, ALM [1 ]
Piñera, C [1 ]
机构
[1] Hosp Univ Valdecilla, Serv Nefrol, Santander, Spain
来源
关键词
D O I
10.1177/039139880402700202
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [1] LEFT-VENTRICULAR HYPERTROPHY IN END-STAGE RENAL-DISEASE
    HARNETT, JD
    PARFREY, PS
    GRIFFITHS, SM
    GAULT, MH
    BARRE, P
    GUTTMANN, RD
    [J]. NEPHRON, 1988, 48 (02): : 107 - 115
  • [2] Inflammation, Left Ventricular Hypertrophy, and Mortality in End-stage Renal Disease
    Cafka, Majlinda
    Rroji, Merita
    Seferi, Saimir
    Barbullushi, Myftar
    Burazeri, Genc
    Spahia, Nereida
    Idrizi, Alma
    Likaj, Erjola
    Seiti, Joana
    Lazaj, Jonida
    Goda, Artan
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (04) : 217 - 223
  • [3] Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease
    Charytan, David
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (06): : 578 - 585
  • [4] The Impact of Change in Volume and Left-Ventricular Hypertrophy on Left-Ventricular Mechanical Dyssynchrony in Children With End-Stage Renal Disease
    Daisuke Kobayashi
    Sheetal R. Patel
    Tej K. Mattoo
    Rudolph P. Valentini
    Sanjeev Aggarwal
    [J]. Pediatric Cardiology, 2012, 33 : 1124 - 1130
  • [5] The Impact of Change in Volume and Left-Ventricular Hypertrophy on Left-Ventricular Mechanical Dyssynchrony in Children With End-Stage Renal Disease
    Kobayashi, Daisuke
    Patel, Sheetal R.
    Mattoo, Tej K.
    Valentini, Rudolph P.
    Aggarwal, Sanjeev
    [J]. PEDIATRIC CARDIOLOGY, 2012, 33 (07) : 1124 - 1130
  • [6] Autonomic dysfunction and left ventricular hypertrophy among patients with end-stage renal disease receiving hemodialysis
    Lin, T. T. L.
    Wu, C. C. W.
    Yang, W. S. Y.
    Lin, L. Y. L.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 254 - 254
  • [7] Left ventricular hypertrophy is a risk factors in patients with end-stage renal disease undergoing chronic dialysis
    Cuadrado, L
    Barretti, P
    Caramori, J
    Tucci, P
    Franco, R
    [J]. HYPERTENSION, 1999, 33 (04) : 1072 - 1072
  • [8] Left ventricular hypertrophy is a risk factors in patients with end-stage renal disease undergoing chronic dialysis
    Cuadrado, L
    Barretti, P
    Caramori, J
    Tucci, P
    Franco, R
    [J]. HYPERTENSION, 1999, 33 (05) : 1272 - 1272
  • [9] Diastolic dysfunction in patients with end-stage renal disease (ESRD) is not due to left ventricular hypertrophy (LVH).
    Ivens, K
    Schannwell, M
    Quasdorff, H
    Leschke, M
    Grabensee, B
    Heering, P
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1171 - A1171
  • [10] IMPACT OF LEFT-VENTRICULAR HYPERTROPHY ON SURVIVAL IN END-STAGE RENAL-DISEASE
    SILBERBERG, JS
    BARRE, PE
    PRICHARD, SS
    SNIDERMAN, AD
    [J]. KIDNEY INTERNATIONAL, 1989, 36 (02) : 286 - 290